Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease
Asa Abeliovich1, Claudia A Doege
1Department of Pathology, Taub Institute, Columbia University Medical Center, 630 West 168(th) Street, New York, NY 10032, USA.
Neuron
|February 17, 2009
Summary
Induced pluripotent stem (iPS) cell technology allows somatic cell reprogramming for potential neurodegenerative disease therapeutics and models. Recent studies demonstrate the utility of patient-derived iPS cells for this purpose.
Area of Science:
- Stem cell biology
- Neuroscience
- Regenerative medicine
Background:
- Somatic cell reprogramming offers a novel approach to generating pluripotent cells.
- Induced pluripotent stem (iPS) cell technology holds promise for disease modeling and cell-based therapies.
- Neurodegenerative disorders represent a significant unmet medical need.
Purpose of the Study:
- To explore the potential of induced pluripotent stem (iPS) cell technology for neurodegenerative disorders.
- To provide proof of concept for the utility of patient-derived iPS cell cultures in studying these diseases.
Main Methods:
- Somatic cell reprogramming to an embryonic stem (ES) cell-like phenotype.
- Initial characterization of neurodegenerative disease patient-derived iPS cell cultures.
Main Results:
- Demonstrated the feasibility of generating iPS cells from neurodegenerative disease patients.
- Established proof of concept for the application of iPS cell technology in this field.
Conclusions:
- Induced pluripotent stem (iPS) cell technology presents a promising avenue for developing cell-based therapeutics for neurodegenerative disorders.
- Patient-derived iPS cells are valuable tools for disease modeling and research into neurodegenerative conditions.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...